The present invention relates to novel substituted imidazo[1,2-b]pyridazine compounds of Formula (I): pharmaceutical compositions thereof, and the use such compounds as corticotropin releasing factor 1 (CRF1) receptor antagonists in the treatment of psychiatric disorders and neurological diseases.
本发明涉及新型的取代
咪唑[1,2-b]
吡啶嗪化合物(I),其制药组合物以及将此类化合物用作促
肾上腺皮质激素释放因子1(CRF1)受体拮抗剂治疗精神障碍和神经疾病。